Micro-mesh technology in routine CAS: the final piece of the puzzle?

EuroIntervention 2018;13:1629-1630. DOI: 10.4244/EIJV13I14A263

Alberto Cremonesi
Alberto Cremonesi*, MD, PhD; Roberto Nerla, MD; Fausto Castriota, MD
Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy

Carotid artery stenting (CAS) is undergoing a new “Renaissance”. Increased operator experience together with advances in technology have provided enough answers to the known controversies traditionally associated with CAS, with a definite improvement in clinical outcomes observed in the latest trials1. The reasons for this deserve an adequate critical appraisal.

It is a fact that carotid angioplasties are emboli-generating procedures. Cerebral embolisation is the main explanation for the post-procedural cerebral events observed after CAS2, with large-burden, friable, thrombotic and ulcerated plaques being associated with a higher risk of embolisation3,4. The use of neuroprotection devices has significantly reduced the ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transcatheter tricuspid intervention: the new challenge of structural valve intervention

Latest news